TREK Diagnostic Systems

TREK Diagnostic Systems is a global leader in providing microbiology solutions, specializing in automated systems for blood culture, microorganism identification, and antibiotic susceptibility testing (AST). The company's flagship products include the VersaTREK Automated Microbial Detection System and the Sensititre product line, which are widely utilized in clinical, pharmaceutical, and veterinary laboratories. These technologies enable rapid and accurate diagnosis of infectious diseases and help clinicians determine the most effective antimicrobial treatments. Founded in 1999 and headquartered in Cleveland, Ohio, TREK was acquired by Thermo Fisher Scientific in 2011. Today, its products continue to serve as critical tools in the fight against antimicrobial resistance and complex microbiological threats.